Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
House of Representatives, Congress." House Hearing, 119th Congress - EXAMINING THE FDA'S REGULATION OF OVER-THE-COUNTER MONOGRAPH DRUGS. Government. U.S. Government Publishing Office https://www.govinfo.gov/app/details/CHRG-119hhrg60082.
House of Representatives, Congress. (2025, April 1). Serial No. 119-14 - EXAMINING THE FDA'S REGULATION OF OVER-THE-COUNTER MONOGRAPH DRUGS. [Government]. U.S. Government Publishing Office. https://www.govinfo.gov/app/details/CHRG-119hhrg60082
House of Representatives, Congress. Serial No. 119-14 - EXAMINING THE FDA'S REGULATION OF OVER-THE-COUNTER MONOGRAPH DRUGS. U.S. Government Publishing Office, (1 Apr 2025), https://www.govinfo.gov/app/details/CHRG-119hhrg60082
House of Representatives, Congress, EXAMINING THE FDA'S REGULATION OF OVER-THE-COUNTER MONOGRAPH DRUGS, GovInfo, (April 1, 2025), https://www.govinfo.gov/app/details/CHRG-119hhrg60082